[go: up one dir, main page]

PT1218009E - Grandulos de quetiapina - Google Patents

Grandulos de quetiapina

Info

Publication number
PT1218009E
PT1218009E PT00960855T PT00960855T PT1218009E PT 1218009 E PT1218009 E PT 1218009E PT 00960855 T PT00960855 T PT 00960855T PT 00960855 T PT00960855 T PT 00960855T PT 1218009 E PT1218009 E PT 1218009E
Authority
PT
Portugal
Prior art keywords
quetiapina
grandulos
Prior art date
Application number
PT00960855T
Other languages
English (en)
Inventor
Brown Daniel Boyd
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10861288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1218009(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1218009E publication Critical patent/PT1218009E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PT00960855T 1999-09-21 2000-09-18 Grandulos de quetiapina PT1218009E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922271.3A GB9922271D0 (en) 1999-09-21 1999-09-21 Formulation

Publications (1)

Publication Number Publication Date
PT1218009E true PT1218009E (pt) 2005-05-31

Family

ID=10861288

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00960855T PT1218009E (pt) 1999-09-21 2000-09-18 Grandulos de quetiapina

Country Status (37)

Country Link
US (3) US6599897B1 (pt)
EP (1) EP1218009B1 (pt)
JP (1) JP2003509461A (pt)
KR (1) KR100748823B1 (pt)
CN (3) CN1899288A (pt)
AR (1) AR032596A1 (pt)
AT (1) ATE288272T1 (pt)
AU (1) AU776292B2 (pt)
BG (1) BG65469B1 (pt)
BR (1) BR0014107A (pt)
CA (1) CA2383131A1 (pt)
CO (1) CO5180585A1 (pt)
CZ (1) CZ301585B6 (pt)
DE (1) DE60017923T2 (pt)
DK (1) DK1218009T3 (pt)
EE (1) EE200200150A (pt)
EG (1) EG24226A (pt)
ES (1) ES2235941T3 (pt)
GB (2) GB9922271D0 (pt)
HK (1) HK1047706B (pt)
HU (1) HUP0203531A3 (pt)
IL (2) IL148440A0 (pt)
IS (1) IS2139B (pt)
MX (1) MXPA02002627A (pt)
MY (1) MY130208A (pt)
NO (1) NO320908B1 (pt)
NZ (1) NZ517549A (pt)
PL (1) PL198824B1 (pt)
PT (1) PT1218009E (pt)
RU (1) RU2256453C2 (pt)
SI (1) SI1218009T1 (pt)
SK (1) SK286884B6 (pt)
TR (1) TR200200716T2 (pt)
TW (1) TWI226832B (pt)
UA (1) UA73529C2 (pt)
WO (1) WO2001021179A1 (pt)
ZA (1) ZA200201709B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
EP1448169A1 (en) * 2001-11-07 2004-08-25 Fujisawa Pharmaceutical Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
JP4514473B2 (ja) * 2004-02-23 2010-07-28 富士通株式会社 コンピュータシステム、中央装置及びプログラム実行方法
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
EP1879874A2 (en) 2005-04-21 2008-01-23 Medichem, S.A. Process for preparing quetiapine and quetiapine fumarate
EP1976487A2 (en) 2006-01-25 2008-10-08 Astron Research Limited Sustained release dosage form of phenothiazine derivatives containing channelizer
TWI389889B (zh) * 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2133338A1 (en) * 2006-05-09 2009-12-16 AstraZeneca AB Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
WO2008012346A1 (en) * 2006-07-28 2008-01-31 Farmaprojects, S. A. Extended release pharmaceutical formulation of metoprolol and process for its preparation
AR062860A1 (es) * 2006-09-15 2008-12-10 Astrazeneca Ab Combinaciones terapeuticas 482
CN101610774B (zh) * 2006-11-03 2012-04-04 萨斯喀彻温大学 治疗脱髓鞘疾病的方法
EP2112923A1 (en) * 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
ATE480227T1 (de) * 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
MX345970B (es) * 2008-02-27 2017-02-28 Intercontinental Great Brands Llc Confiteria de regiones multiples.
PT2262486E (pt) 2008-08-01 2013-03-27 Tovarna Zdravil D D Novo Mesto Krka Composição de quetiapina
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
CN102781236B (zh) 2009-12-31 2015-01-07 凯姆制药公司 喹硫平的氨基酸缀合物、其制备和使用方法
EP2544536B1 (en) 2010-03-11 2018-12-12 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
WO2011146009A1 (en) 2010-05-20 2011-11-24 Targacept Inc. New process for the preparation of aryl substituted olefinic amines
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
PE20231213A1 (es) * 2020-04-29 2023-08-17 Stepan Co Composiciones solidas que contienen amina, amina protonada o compuestos de amonio cuaternario

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
ES2054259T3 (es) * 1989-08-31 1994-08-01 Takeda Chemical Industries Ltd Composicion de vitamina b12.
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
JPH06100602A (ja) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd 経口固形製剤およびその製造方法
US5397576A (en) * 1992-09-23 1995-03-14 Hoffmann-La Roche Inc. Spray triturated micronutrient compositions
EP0667866B1 (en) * 1992-11-09 1998-03-11 Knoll AG 1,4-benzothiazepines useful as neurological agents
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
JP2001501207A (ja) * 1996-09-24 2001-01-30 イーライ・リリー・アンド・カンパニー コーティングされた粒子製剤
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation

Also Published As

Publication number Publication date
TWI226832B (en) 2005-01-21
JP2003509461A (ja) 2003-03-11
US7022692B2 (en) 2006-04-04
AU7302300A (en) 2001-04-24
CN1626094A (zh) 2005-06-15
NO20021394L (no) 2002-03-20
NO20021394D0 (no) 2002-03-20
EG24226A (en) 2008-11-10
NZ517549A (en) 2003-10-31
CZ301585B6 (cs) 2010-04-21
GB0021406D0 (en) 2000-10-18
PL357369A1 (en) 2004-07-26
IL148440A (en) 2007-07-04
CZ2002974A3 (cs) 2002-06-12
IS6308A (is) 2002-03-19
HK1047706A1 (en) 2003-03-07
AR032596A1 (es) 2003-11-19
SK3722002A3 (en) 2002-07-02
BR0014107A (pt) 2002-08-20
CN1374867A (zh) 2002-10-16
CA2383131A1 (en) 2001-03-29
IL148440A0 (en) 2002-09-12
HUP0203531A2 (hu) 2003-02-28
KR20020033186A (ko) 2002-05-04
NO320908B1 (no) 2006-02-13
EP1218009B1 (en) 2005-02-02
BG106509A (en) 2002-12-29
CN1331472C (zh) 2007-08-15
MXPA02002627A (es) 2002-07-30
DE60017923D1 (de) 2005-03-10
BG65469B1 (bg) 2008-09-30
EE200200150A (et) 2003-04-15
EP1218009A1 (en) 2002-07-03
HK1047706B (en) 2005-06-10
HUP0203531A3 (en) 2004-12-28
SK286884B6 (sk) 2009-07-06
CN1899288A (zh) 2007-01-24
DK1218009T3 (da) 2005-05-09
ATE288272T1 (de) 2005-02-15
KR100748823B1 (ko) 2007-08-13
CN1188130C (zh) 2005-02-09
UA73529C2 (uk) 2005-08-15
WO2001021179A1 (en) 2001-03-29
GB9922271D0 (en) 1999-11-17
US20040228914A1 (en) 2004-11-18
TR200200716T2 (tr) 2002-06-21
DE60017923T2 (de) 2006-01-12
US6599897B1 (en) 2003-07-29
MY130208A (en) 2007-06-29
SI1218009T1 (en) 2005-06-30
US20060159768A1 (en) 2006-07-20
IS2139B (is) 2006-08-15
RU2256453C2 (ru) 2005-07-20
AU776292B2 (en) 2004-09-02
ZA200201709B (en) 2003-05-28
CO5180585A1 (es) 2002-07-30
PL198824B1 (pl) 2008-07-31
ES2235941T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I1 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
ATA51899A (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
PT1218009E (pt) Grandulos de quetiapina
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50009570D1 (de) Wechselcorrugator
PT1218096E (pt) Microcapsulas de libertacao variavel
DE50007953D1 (de) Beleuchtungsanordung
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
DE50008613D1 (de) Sicherungsring
PT1235566E (pt) Formulacao injectavel de valnemulina
DE50000805D1 (de) Aufsitzspanner
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50012482D1 (de) Tibiamarknagel
DE50003660D1 (de) Diacylhydrazinderivate
DE50003259D1 (de) Textilie
DE50006013D1 (de) Anschlagpuffer
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
DE50009208D1 (de) Hydroxyphenylvinylthiazole
ATE440824T1 (de) Nitro-sulfobenzamide